These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 1436527)

  • 1. Changes in lymphocyte subsets in myasthenia gravis: correlation with level of antibodies to acetylcholine receptor and age of patient.
    Schlesinger I; Rabinowitz R; Brenner T; Abramsky O; Schlesinger M
    Neurology; 1992 Nov; 42(11):2153-7. PubMed ID: 1436527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of thymectomy and glucocorticoid therapy on peripheral lymphocytes in myasthenia gravis].
    Huang Y; Xu X; Lin J
    Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):514-7. PubMed ID: 8697907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.
    Yang Y; Zhang M; Ye Y; Ma S; Fan L; Li Z
    Neurol Sci; 2017 Sep; 38(9):1599-1608. PubMed ID: 28578482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in clinical and immunological status after post-thymectomized irradiation for invasive thymoma with myasthenia gravis].
    Ishida S
    Rinsho Shinkeigaku; 1996 May; 36(5):629-32. PubMed ID: 8905980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.
    Yi Q; Ahlberg R; Pirskanen R; Lefvert AK
    Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of immunologic treatment on lymphocyte subsets in patients with myasthenia gravis].
    Han Z; Xu W; Liu M; Wei Y; Lei S
    Zhonghua Nei Ke Za Zhi; 1999 Oct; 38(10):656-9. PubMed ID: 11798700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional characterization of T cells from patients with myasthenia gravis.
    Mokhtarian F; Pino M; Ofosu-Appiah W; Grob D
    J Clin Invest; 1990 Dec; 86(6):2099-108. PubMed ID: 1979338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD5+ B cells and myasthenia gravis.
    Araga S; Kishimoto M; Adachi A; Nakayasu H; Takenaka T; Takahashi K
    Autoimmunity; 1995; 20(2):129-34. PubMed ID: 7578869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic T cells in early stages of myasthenia gravis: increase in the number and prevalence correlated to clinical improvement in patients.
    Yi Q; Pirskanen R; Lefvert AK
    Scand J Immunol; 1996 Dec; 44(6):630-7. PubMed ID: 8972746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The regulation of anti-acetylcholine receptor antibody production by T cells responding in autologous mixed lymphocyte reaction in patients with myasthenia gravis].
    Chiu HC; Hung TP; Hsieh KH
    Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):422-6. PubMed ID: 2955077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmapheresis therapy of myasthenia gravis].
    Sano M; Utsugisawa K; Tohgi H
    Nihon Rinsho; 1992 Jan; 50 Suppl():337-44. PubMed ID: 1578705
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of myasthenia serum and anti-acetylcholine receptor monoclonal antibody on the distributions of T-cell subsets in myasthenia patients and normal subjects.
    Chiu HC; Hsieh KH; Hung TP; Richman DP; Arnason BG
    Asian Pac J Allergy Immunol; 1985 Jun; 3(1):30-6. PubMed ID: 3925962
    [No Abstract]   [Full Text] [Related]  

  • 15. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
    Lal RB; Rudolph DL; Schmid DS; Lairmore MD
    Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of anti-acetylcholine receptor antibodies by CD5- B cells from peripheral blood of myasthenia gravis patients.
    Heidenreich F; Jovin T
    J Neurol; 1996 Jan; 243(1):57-62. PubMed ID: 8869388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.
    Hohlfeld R; Kalies I; Kohleisen B; Heininger K; Conti-Tronconi B; Toyka KV
    Neurology; 1986 May; 36(5):618-21. PubMed ID: 3486379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.